8-K
Current Report
Adaptimmune Therapeutics PLC Filed Acc 0001558370-22-018828
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading adap-20221219x8k.htm…